CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
Recruiting · NCT05726526 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Manitoba
View the official record on ClinicalTrials.gov →Interventions studied
VIEWER virtual care platform
What this trial is about
The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- \>18 years of age
- Patient or primary caregiver can read and speak English
- Patient or patients substitute decision maker is able to provide informed consent
- Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e. weight, BP, etc.)
- Have stage 5 CKD (2 measurements of eGFR \<15ml/min/1.73m2); eGFR will be calculated with the CKD-EPI equation, or have \>40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation
- Followed in a multidisciplinary CKD clinic
Exclusion criteria
- Inability of self or caregiver assisted self-monitoring using VIEWER
Where it is running
5 locations listed.
- St. Boniface Hospital - Winnipeg, Manitoba, Canada
- Chronic Disease Innovation Centre, Seven Oaks Hospital - Winnipeg, Manitoba, Canada
- Health Sciences Centre - Winnipeg, Manitoba, Canada
- London Health Sciences Centre - London, Ontario, Canada
- Scarborough Health Network - General Hospital - Scarborough Village, Ontario, Canada